Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-COMP-14 in Aggressive B-cell NHL with Cardiovascular Risk
NCT00849355Phase 2Unknown
- Sponsor
- Asociación para el Estudio de la Hematología del Hospital Doctor Peset
- Start
- Aug 2008
- Primary completion
- Nov 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in B-cell non-Hodgkin lymphoma, sponsored by Asociación para el Estudio de la Hematología del Hospital Doctor Peset. Status: unknown.
02
Drugs
doxorubicin
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00849355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849355.